Drug
Aro Enac
Aro Enac: highest development phase Phase 1/2, developed by Arrowhead Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Arrowhead Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARO-ENaC NCT04375514 | Phase 1/2 | Cystic Fibrosis, Pulmonary |
Latest
No recent events.
Follow Aro Enac on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.